GlassScriptPhysician profile
Dante A Marra
NPI 1295807725
$6,308.73
in general payments reported to CMS, 2019-2025
26 companies · $418 in 2025
The $418 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $619 · 2021: $2,476 · 2022: $1,606 · 2023: $402 · 2024: $416 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,236.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bone Support INC. | $1,500.00 | 2022 | |
| Arthrex, INC. | $1,496.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $1,264.17 | 2019-2025 | Persona, Comprehensive Shoulder System, Rosa |
| Mid-Atlantic Surgical Systems, LLC | $480.82 | 2021-2024 | |
| Pacira Therapeutics, INC. | $264.10 | 2019-2021 | |
| Vericel Corporation | $244.32 | 2019-2025 | Maci |
| Baxter Healthcare | $133.68 | 2023 | Tisseel |
| Innovation Technologies INC | $132.25 | 2019-2021 | |
| Bioventus LLC | $127.03 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $121.89 | 2020-2025 | Variax, Insignia, Trident |
| Cumberland Pharmaceuticals, INC. | $99.13 | 2020-2022 | |
| Horizon Therapeutics Plc | $63.19 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $60.42 | 2019-2020 | |
| Ethicon US, LLC | $55.36 | 2020-2025 | Vistaseal |
| Smith+Nephew, INC. | $53.27 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $45.34 | 2023 | Iovera, Exparel, Zilretta |
| Medtronic USA, INC. | $42.32 | 2019 | |
| Avanos Medical | $18.67 | 2022 | |
| Medtronic, INC. | $17.17 | 2021 | |
| Depuy Synthes Sales INC. | $15.50 | 2020 | |
| Collegium Pharmaceutical, INC. | $14.39 | 2019 | |
| Pfizer INC. | $13.58 | 2019 | |
| Wright Medical Technology, INC. | $13.26 | 2019 | |
| Sonex Health, INC. | $12.65 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.43 | 2022 | |
| Heron Therapeutics, INC. | $7.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dante Marra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.